Key Clinical message Eculizumab in pregnancy has been reported to be effective in improving outcomes in patients with paroxysmal nocturnal hemoglobinuria. However, a cesarean section may result in surgery‐triggered hemolysis.
Dongping Li +8 more
doaj +1 more source
Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria [PDF]
K. Kawagoe +7 more
openalex +1 more source
Differential expression of glycosylphosphatidylinositol-anchored proteins in a murine T cell hybridoma mutant producing limiting amounts of the glycolipid core. Implications for paroxysmal nocturnal hemoglobinuria. [PDF]
Lawrence J. Thomas +7 more
openalex +1 more source
Pregnancy with Paroxysmal Nocturnal Hemoglobinuria: A Case Series with Review of the Literature
Yara Mohammad Al-Dosari +3 more
openalex +1 more source
Efficacy of SB12 (Eculizumab Biosimilar) in Asian and Non-Asian Patients with Paroxysmal Nocturnal Hemoglobinuria: Subgroup Analysis of a Global Phase III Randomized Controlled Trial [PDF]
Jun Ho Jang +8 more
openalex +1 more source
Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry [PDF]
Jun Ho Jang +8 more
openalex +1 more source
Current Insights into Paroxysmal Nocturnal Hemoglobinuria
-
Wanchai Wanachiwanawin
doaj
Confirmation of a Structural Abnormity in the Stroma of Erythrocytes from Paroxysmal Nocturnal Hemoglobinuria (PNH) After Hemolysis in Distilled Water [PDF]
H Braunsteiner, E Gisinger, F. Pakesch
openalex +1 more source

